| Title: | Helicobacter pylori infection and metabolic dysfunction-associated steatotic liver disease: a prospective study and meta-analysis. |
| Journal: | Cancer Epidemiology Biomarkers & Prevention |
| Published: | 3 Jun 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42233960/ |
| DOI: | https://doi.org/10.1158/1055-9965.epi-26-0038 |
Publication 19938
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Helicobacter pylori (H. pylori) infection and metabolic dysfunction-associated steatotic liver disease (MASLD) are significant global health concerns, but their association remains unclear, with evidence mainly from cross-sectional studies and Asian populations.</p>
METHODS: We analyzed UK Biobank (UKB) participants aged 40-69 years with objectively measured H. pylori serostatus data (N=4,246). Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs), adjusting for demographic, lifestyle, and cardiometabolic factors. We meta-analyzed seven prospective cohorts (all from non-European populations) and the UKB (8 cohorts in total with 36,145 participants and 6,979 cases) to evaluate the association between H. pylori seropositivity and MASLD risk.</p>
RESULTS: About 35.1% of the participants were seropositive for H. pylori in the UKB. With median follow-up of 11.1 years, we identified 32 MASLD cases. H. pylori seropositivity was marginally associated with higher MASLD risk (HR, 1.88; 95% CI, 0.92-3.82), whereas CagA seropositivity was significantly associated with higher risk (2.40; 1.17-4.92). Participants seropositive for both H. pylori and CagA had a higher MASLD risk than participants seronegative for both markers (2.58; 1.19-5.61). The meta-analysis showed that H. pylori was associated with a 24% higher MASLD risk (Risk Ratio, 1.24; 95% CI, 1.17-1.31).</p>
CONCLUSIONS: H. pylori infection, especially CagA seropositivity, was associated with higher MASLD risk in prospective studies.</p>
IMPACT: Our findings support a potential role of H. pylori virulence serology (CagA) in MASLD development. If confirmed, these findings could have implications for risk stratification and inform targeted eradication or prevention strategies.</p>
17 Authors
- Longgang Zhao
- Yun Chen
- Xinyuan Zhang
- Catherine Mezzacappa
- Xiaomei Ma
- Bubu Banini
- Jung Eun Lee
- Chen Liu
- Xuchen Zhang
- Ann W Hsing
- Mindie H Nguyen
- Chul S Hyun
- M Constanza Camargo
- Katherine A McGlynn
- Lifang Hou
- Tamar H Taddei
- Xuehong Zhang
1 Application
| Application ID | Title |
|---|---|
| 87303 | Improving liver health in humans: Elucidating the role of genetics, biomarkers, and environment in liver biology, etiology, progression, and prognosis |
Enabling scientific discoveries that improve human health